SiDMAP Launches a Metabolomics Service for Early Detection of Drug-Induced Liver and Kidney Toxicity
News Oct 24, 2008
Using its proprietary metabolomics technology platform, SiDMAP is able to monitor changes in vital metabolite fluxes in response to drug treatment to quickly determine organ toxicity before structural or morphological damage occurs.
With recent advances in drug discovery, large numbers of potential new drugs have been identified. Yet, a big obstacle that remains in drug discovery and development is the lack of a reliable way to screen these drug candidates to determine toxicity levels early enough in the process. Based on research performed by SiDMAP in collaboration with the Center for Metabolomics at the FDA National Center for Toxicological Research, SiDTox' now also includes a cost-effective and non-invasive test which promises to better enable pharmaceutical researchers to rapidly detect drug-induced toxicity prior to organ damage.
'Using non-invasive and non-emitting 13C glucose tracer, we are able to quantify synthesis and turnover of selected metabolites in real time in order to develop the necessary translational plasma, tissue and urine isotopomer profiles routinely applicable as toxicity biomarkers in humans,' commented Dr. Laszlo Boros, SiDMAP's Chief Scientific Advisor. 'Our tracer substrate approach utilizes the accurate assessment and quantification of cross-talk and flux alterations among physiologically vital substrate and product pools and their disruption to provide early indications of the presence and mechanisms of drug-induced toxicity, as seen in the FDA study involving valproic acid.'
Presently, drug toxicities, in general, are assessed by morphological markers of organ damage, proteomic and metabonomics methods and gene expression profiles. However, there remains a need for rapid markers to detect drug toxicity prior to irreversible organ damage.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE
Measuring hand grip can help identify youths who could benefit from lifestyle changes, says new research. While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes - including cardiovascular and metabolic diseases - this is the first to do so for adolescent health over time.READ MORE
Virtually all functions in our bodies require precise interactions between radically different types of molecules. A new study aims to understand how RNA molecules pair with intended protein partners. Researchers hope that they eventually will be able to predict and manipulate these partnerships that have been carved through millions of years of evolution.READ MORE